PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.44%
Revenue growth at 75-90% of 9843.T's 7.65%. Bill Ackman would push for innovation or market expansion to catch up.
10.34%
Gross profit growth above 1.5x 9843.T's 3.83%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
32.32%
EBIT growth above 1.5x 9843.T's 11.54%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
35.65%
Operating income growth above 1.5x 9843.T's 17.09%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
36.95%
Net income growth above 1.5x 9843.T's 16.17%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-31.52%
Negative EPS growth while 9843.T is at 16.19%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-31.52%
Negative diluted EPS growth while 9843.T is at 16.07%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
100.00%
Share count expansion well above 9843.T's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
100.00%
Diluted share count expanding well above 9843.T's 0.09%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.06%
Negative 10Y revenue/share CAGR while 9843.T stands at 37.54%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-9.06%
Negative 5Y CAGR while 9843.T stands at 37.54%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.15%
Negative 3Y CAGR while 9843.T stands at 21.89%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
15.25%
Net income/share CAGR at 75-90% of 9843.T's 17.52%. Bill Ackman would press for strategic moves to boost long-term earnings.
15.25%
5Y net income/share CAGR at 75-90% of 9843.T's 17.52%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
6.59%
3Y net income/share CAGR 1.25-1.5x 9843.T's 5.57%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.61%
Negative 3Y equity/share growth while 9843.T is at 62.82%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-99.47%
Firm’s AR is declining while 9843.T shows 21.69%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.66%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.83%
Asset growth well under 50% of 9843.T's 4.88%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-47.19%
We have a declining book value while 9843.T shows 4.62%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-76.30%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
52.94%
SG&A growth well above 9843.T's 27.06%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.